These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Striatal Direct and Indirect Pathway Output Structures Are Differentially Altered in Mouse Models of Huntington's Disease. Barry J; Akopian G; Cepeda C; Levine MS J Neurosci; 2018 May; 38(20):4678-4694. PubMed ID: 29691329 [TBL] [Abstract][Full Text] [Related]
4. Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF. Cepeda C; Starling AJ; Wu N; Nguyen OK; Uzgil B; Soda T; André VM; Ariano MA; Levine MS J Neurosci Res; 2004 Dec; 78(6):855-67. PubMed ID: 15505789 [TBL] [Abstract][Full Text] [Related]
5. Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington's disease. Indersmitten T; Tran CH; Cepeda C; Levine MS J Neurophysiol; 2015 Apr; 113(7):2953-66. PubMed ID: 25673747 [TBL] [Abstract][Full Text] [Related]
6. Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease. Starling AJ; André VM; Cepeda C; de Lima M; Chandler SH; Levine MS J Neurosci Res; 2005 Nov; 82(3):377-86. PubMed ID: 16211559 [TBL] [Abstract][Full Text] [Related]
7. Alterations in Hippocampal Inhibitory Synaptic Transmission in the R6/2 Mouse Model of Huntington's Disease. Dargaei Z; Liang X; Serranilla M; Santos J; Woodin MA Neuroscience; 2019 Apr; 404():130-140. PubMed ID: 30797895 [TBL] [Abstract][Full Text] [Related]
8. Calcium dysregulation and compensation in cortical pyramidal neurons of the R6/2 mouse model of Huntington's disease. Oikonomou KD; Donzis EJ; Bui MTN; Cepeda C; Levine MS J Neurophysiol; 2021 Oct; 126(4):1159-1171. PubMed ID: 34469694 [TBL] [Abstract][Full Text] [Related]
9. A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1J mouse model of Huntington's disease. Ruskin DN; Ross JL; Kawamura M; Ruiz TL; Geiger JD; Masino SA Physiol Behav; 2011 Jul; 103(5):501-7. PubMed ID: 21501628 [TBL] [Abstract][Full Text] [Related]
10. Brain Cholesterol Synthesis and Metabolism is Progressively Disturbed in the R6/1 Mouse Model of Huntington's Disease: A Targeted GC-MS/MS Sterol Analysis. Kreilaus F; Spiro AS; Hannan AJ; Garner B; Jenner AM J Huntingtons Dis; 2015; 4(4):305-18. PubMed ID: 26639223 [TBL] [Abstract][Full Text] [Related]
11. Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. Cepeda C; Hurst RS; Calvert CR; Hernández-Echeagaray E; Nguyen OK; Jocoy E; Christian LJ; Ariano MA; Levine MS J Neurosci; 2003 Feb; 23(3):961-9. PubMed ID: 12574425 [TBL] [Abstract][Full Text] [Related]
12. Early GABAergic transmission defects in the external globus pallidus and rest/activity rhythm alteration in a mouse model of Huntington's disease. Du Z; Chazalon M; Bestaven E; Leste-Lasserre T; Baufreton J; Cazalets JR; Cho YH; Garret M Neuroscience; 2016 Aug; 329():363-79. PubMed ID: 27217211 [TBL] [Abstract][Full Text] [Related]
13. Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington's Disease. Holley SM; Joshi PR; Parievsky A; Galvan L; Chen JY; Fisher YE; Huynh MN; Cepeda C; Levine MS eNeuro; 2015; 2(1):. PubMed ID: 26203463 [TBL] [Abstract][Full Text] [Related]
14. Major Contribution of Somatostatin-Expressing Interneurons and Cannabinoid Receptors to Increased GABA Synaptic Activity in the Striatum of Huntington's Disease Mice. Holley SM; Galvan L; Kamdjou T; Dong A; Levine MS; Cepeda C Front Synaptic Neurosci; 2019; 11():14. PubMed ID: 31139071 [TBL] [Abstract][Full Text] [Related]
19. Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease. Rocher AB; Gubellini P; Merienne N; Boussicault L; Petit F; Gipchtein P; Jan C; Hantraye P; Brouillet E; Bonvento G Neurobiol Dis; 2016 Feb; 86():131-9. PubMed ID: 26626081 [TBL] [Abstract][Full Text] [Related]
20. Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease. Ferrante A; Martire A; Pepponi R; Varani K; Vincenzi F; Ferraro L; Beggiato S; Tebano MT; Popoli P Neurobiol Dis; 2014 Nov; 71():193-204. PubMed ID: 25132555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]